Clinical Trial: Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: A Pilot Trial of Nelfinavir for the Lytic Activation and Treatment of Gammaherpesvirus-Related Tumors

Brief Summary: The goals of this study is to determine if nelfinavir can target Epstein-Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV) in patients with certain cancers.